Jan 16, 2024
Chrysalis Ketamine (888-836-4334) has announced its ketamine infusion therapy for individuals in Malibu suffering from treatment-resistant depression.

Thousand Oaks, United States - January 16, 2024 /NewsNetwork/ —
The latest announcement responds to a recent rise in the prevalence of treatment-resistant depression, with Johns Hopkins Medicine reporting that it affects up to 30% of adults with major depressive disorder. With its ketamine infusion therapy, Chrysalis Ketamine offers an alternative form of treatment for depression where other forms of antidepressant medication have failed.
For more details, please visit https://chrysalisketamine.com/ketamine-therapy-near-malibu-ca/
Antidepressants, such as sertraline, are often the first-line treatment for depression, however not all patients respond to this form of medication. Unlike traditional SSRIs, the clinic’s new ketamine IV infusion therapy provides patients with almost instantaneous relief from their depressive symptoms.
“The promptness of ketamine in yielding an antidepressant effect occurs because this drug bypasses the conventional serotonin path and goes straight to switching on glutamate,” explains the clinic. This neurotransmitter is responsible for regulating mood and emotion and is therefore helpful in treating common symptoms of depression such as persistent feelings of sadness, mood swings and irritability.
The ketamine therapy provided at Chrysalis Ketamine is offered intravenously over 40-50 minutes, resulting in immediate psychoactive effects. All treatments are administered in private rooms and patients are monitored carefully throughout.
The team at Chrysalis Ketamine works together with patients to determine individualized treatment plans according to their goals and needs. The clinic recommends six infusions, over a span of two to three weeks, to provide the best relief from depressive symptoms.
Read more about Chrysalis Ketamine service for treatment-resistant depression by visiting https://chrysalisketamine.com/depression-treatment-thousand-oaks-ca/
Dr. Karpanian explains that ketamine works best in conjunction with talk therapy from a registered psychotherapy professional. Therefore, the clinic also offers therapist referrals for patients interested in ketamine-assisted psychotherapy. “The process works best when approached holistically,” says Dr. Karpanian. “Good social support, supplemental and complementary therapy from your therapist or psychiatrist along with good sleep, diet and exercise are very important.”
Although primarily treating depression, Chrysalis Ketamine’s infusions have also been proven to treat the symptoms of other mental health conditions including anxiety, bipolar disorder, PTSD, OCD, and more.
One satisfied patient said: “Dr. Karpanian is wonderful. He offers a thoughtful, gentle, and empathetic approach to his work. He values connection and collaboration to help alleviate his patients' symptoms. He is a very caring doctor.”
Interested parties can find more information by visiting https://chrysalisketamine.com/faqs/
Contact Info:
Name: Hagop Karpanian
Email: Send Email
Organization: Chrysalis Ketamine
Address: 430 E Avenida De Los Arboles Suite 205, Thousand Oaks, California 91360, United States
Phone: +1-888-836-4334
Website: https://www.chrysalisketamine.com
Source: NewsNetwork
Release ID: 89118854
If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting [email protected]. Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.